Balaji Amines Limited Reports Audited Financial Results for Fiscal Year 2026

Balaji Amines Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a consolidated revenue of ₹403 crore for Q4FY26 and a net profit of ₹65 crore. Despite external disruptions during the final month of the year, the company demonstrated operational resilience, maintaining stable volumes and continuing progress on its strategic expansion projects across multiple units.

Financial Performance Overview

For the fourth quarter of the financial year 2026, Balaji Amines achieved a consolidated revenue of ₹403 crore, compared to ₹361 crore in the previous quarter. The company recorded an EBITDA of ₹102 crore, resulting in an EBITDA margin of 25%. Net profit for the quarter stood at ₹65 crore, with a diluted EPS of ₹19.99. On a standalone basis, the company maintains its status as a zero-debt organization.

Operational Highlights

Total sales volumes reached 27,341 MT in Q4FY26, up from 25,871 MT in the same period last year. The production volume breakdown for the quarter included 7,746 MT of Amines, 8,935 MT of Amines Derivatives, and 10,660 MT of Specialty Chemicals. Management attributed the stable operational performance to prudent inventory planning and consistent demand across core segments, which helped mitigate geopolitical supply chain challenges.

Strategic Expansion and Future Projects

The company is moving forward with several key projects aimed at long-term growth:

  • DME Plant (Unit-IV): Expected to be commissioned in the first quarter of FY 2026-27, targeting the aerosol and LPG replacement industries.
  • N-Methyl Morpholine (NMM): A 5,000 TPA capacity facility currently under execution for commissioning in FY 2026-27.
  • Acetonitrile Plant: An improved process-based facility expected to be operational by the second quarter of FY 2026-27.
  • Subsidiary Expansion: Balaji Speciality Chemicals Limited has received Mega Project status from the Government of Maharashtra for a ₹750 crore expansion project, which will focus on products like Hydrogen Cyanide and EDTA.

Management Commentary

Managing Director Mr. D. Ram Reddy noted that the company successfully navigated temporary external disruptions in March 2026 through disciplined execution. Looking ahead, the focus remains on enhancing plant utilization, leveraging operating efficiencies, and ramping up the production of higher-value segments, such as electronic-grade DMC and DMF, to drive future growth.

Source: BSE

Previous Article

Le Travenues Technology Limited Monitoring Agency Reports for Quarter Ended March 31, 2026

Next Article

Maruti Suzuki India Consolidated Financial Results for FY2025